Zynerba Pharmaceuticals Inc (ZYNE) Annual Balance Sheets

Annual · GAAP · USD millions
Access ZYNE quarterly Balance Sheets →
Balance sheet data covering Zynerba Pharmaceuticals Inc–Dec 31 2018 offers a view into how Dec 31 2022's financial position has changed alongside business activity.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2022)
(Dec 31 2021) (Dec 31 2020) (Dec 31 2019) (Dec 31 2018)
Assets
Cash & cash equivalent50.64
Cash & Short-term Investments50.00
Other Current Assets1.23
Prepaid Expense And Other Assets Current2.91
Total Current Assets54.78
Equipment/Property/Plant Net0.41
Other Assets, Noncurrent0.34
Tax Incentive Receivable Current1.23
Total Assets55.52
Liabilities
Accounts Payable, Current AC1.94
Accrued Liabilities, Current AC7.01
Other Liabilities, Current0.21
Total Current Liabilities9.17
Total Long-term Debt0.00
Other liabilities, Noncurrent0.12
OperatingLeaseLiabilityNoncurrent0.12
Operating Lease Liability Current0.21
Total Liabilities9.29
Stockholders' Equity
Common Stock Value0.05
Additional Paid In Capital Common Stock320.70
Retained Earnings / Accumulated Deficit-274.52
Other Equity0.00
Common Stockholder's Equity46.23
Total Stockholder's Equity46.23
Liabilities & Stockholder's Equity55.52
4 historic quarters locked

Sign in to unlock the full Zynerba Pharmaceuticals Inc balance sheet history.

About Zynerba Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001558370-23-014705

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License